Long-term follow-up outcomes of perinatally HIV-infected adolescents: infection control but school failure
- PMID: 20167634
- DOI: 10.1093/tropej/fmq008
Long-term follow-up outcomes of perinatally HIV-infected adolescents: infection control but school failure
Abstract
Perinatally human immunodeficiency virus (HIV)-infected children are fighting acquired immune deficiency syndrome (AIDS) and becoming adolescents. The objective of this study was to examine long-term outcomes among perinatally HIV-1-infected adolescents. Cross-sectional clinical and laboratory data were collected for 49 perinatally HIV-infected adolescents followed at the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP's) Hospital from 1987 to 2007. The mean age of these adolescents was 12.5 years, the majority were female (73.5%) with a mean follow-up duration of 9.0 years, 71.4% of adolescents had no signs of HIV infection, 81.6% had normal CD4(+) lymphocyte count, and 53.1% had undetectable HIV viral load. HIV disclosure to the adolescent was reported in 31 (63.3%) participants. The majority were in school (89.8%) but failure and drop-out were reported by 51% and 28.6% of the subjects, respectively. All five domains of quality of life (QOL) measured revealed high scores. The majority of long-term adolescent survivors showed HIV-infection control and high scores of QOL, but with problems in schooling functioning that need early detection and intervention.
Similar articles
-
Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10).Clin Infect Dis. 2010 Jul 15;51(2):214-24. doi: 10.1086/653674. Clin Infect Dis. 2010. PMID: 20536367
-
Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.Pediatrics. 2005 Feb;115(2):e173-82. doi: 10.1542/peds.2004-1693. Epub 2005 Jan 3. Pediatrics. 2005. PMID: 15629958
-
Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.Clin Infect Dis. 2008 Feb 15;46(4):507-15. doi: 10.1086/526524. Clin Infect Dis. 2008. PMID: 18199042
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Optimizing antiretroviral therapy in adolescents with perinatally acquired HIV-1 infection.Expert Rev Anti Infect Ther. 2010 Dec;8(12):1403-16. doi: 10.1586/eri.10.129. Expert Rev Anti Infect Ther. 2010. PMID: 21133665 Review.
Cited by
-
The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.J Int AIDS Soc. 2013 Jun 18;16(1):18555. doi: 10.7448/IAS.16.1.18555. J Int AIDS Soc. 2013. PMID: 23782474 Free PMC article. Review.
-
Characteristics of HIV infected adolescents in Latin America: results from the NISDI pediatric study.J Trop Pediatr. 2011 Jun;57(3):165-72. doi: 10.1093/tropej/fmq068. Epub 2010 Aug 4. J Trop Pediatr. 2011. PMID: 20685800 Free PMC article.
-
Adolescents with HIV and transition to adult care in the Caribbean, Central America and South America, Eastern Europe and Asia and Pacific regions.J Int AIDS Soc. 2017 May 16;20(Suppl 3):21475. doi: 10.7448/IAS.20.4.21475. J Int AIDS Soc. 2017. PMID: 28530040 Free PMC article.
-
Community-based accompaniment for adolescents transitioning to adult HIV care in urban Peru: a pilot study.AIDS Behav. 2022 Dec;26(12):3991-4003. doi: 10.1007/s10461-022-03725-2. Epub 2022 Jul 5. AIDS Behav. 2022. PMID: 35788925 Free PMC article.
-
Neurodevelopment: The Impact of Nutrition and Inflammation During Adolescence in Low-Resource Settings.Pediatrics. 2017 Apr;139(Suppl 1):S72-S84. doi: 10.1542/peds.2016-2828I. Pediatrics. 2017. PMID: 28562250 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials